Alx Oncology Holdings (ALXO) Debt Ratio (2019 - 2026)

Alx Oncology Holdings' Debt Ratio history runs 8 years deep, the most recent figure standing at 0.05 for Q1 2026.

• In Q1 2026, Debt Ratio fell 42.12% year-over-year to 0.05; the TTM figure through Mar 2026 stood at 0.05 (down 42.12% YoY), while the FY2025 annual figure was 0.17, up 146.35% from the prior year.
• Debt Ratio came in at 0.05 for Q1 2026 at Alx Oncology Holdings, down from 0.17 in the prior quarter.
• In the past five years, Debt Ratio ranged from a high of 0.17 in Q4 2025 to a low of 0.01 in Q2 2022.
• A 5-year average of 0.06 and a median of 0.05 in 2024 frame the typical range for Debt Ratio.
• Across the five-year window, Debt Ratio surged 351.92% in 2022 and slumped 42.12% in 2026, its largest moves.
• Alx Oncology Holdings' Debt Ratio stood at 0.04 in 2022, then climbed by 10.33% to 0.04 in 2023, then soared by 68.65% to 0.07 in 2024, then surged by 146.35% to 0.17 in 2025, then tumbled by 71.09% to 0.05 in 2026.
• According to Business Quant data, Debt Ratio over the past three periods registered 0.05, 0.17, and 0.12 for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison